Neha P Agarwal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Neha P Agarwal has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Girdhar M Taori
Biochemistry Research Laboratory, Central India Institute of Medical Sciences, 88/2 Bajaj Nagar, Nagpur-440010, India
1 shared publication - Hatim F. Daginawala
Biochemistry Research Laboratory, Central India Institute of Medical Sciences, Nagpur, India
1 shared publication - Hemant J Purohit
Environmental Genomics Unit, NEERI, Nehru Marg, Nagpur-440020, India
1 shared publication - Nitin H Chandak
Biochemistry Research Laboratory, Central India Institute of Medical Sciences, 88/2 Bajaj Nagar, Nagpur-440010, India
1 shared publication - Rajpal Singh Kashyap
Research Centre, Central India Institute of Medical Sciences, Nagpur, India
1 shared publication - Rani P Kainthla
Biochemistry Research Laboratory, Central India Institute of Medical Sciences, 88/2 Bajaj Nagar, Nagpur-440010, India
1 shared publication
Latest Publications
- Open Access
- 22 October 2004
- Published by Springer Nature in BMC Neurology
- Vol. 4 (1) , 16
Differential diagnosis of tuberculous meningitis from partially-treated pyogenic meningitis by cell ELISA
Background: Tuberculous meningitis (TBM) is a major global health problem, and it is sometimes difficult to perform a differential diagnosis of this disease from other diseases, particularly partially-treated pyogenic meningitis (PTPM). In an earlier study, we demonstrated the presence of a 30-kD protein antigen in cerebrospinal fluid (CSF) of TBM patients. We have also shown that lymphocytes from CSF of TBM patients respond differently to this antigen than do those from PTPM patients. The purpose of this study was to develop an assay that can discriminate between TBM and PTPM. Methods: We developed a cell enzyme-linked immunosorbant assay (Cell ELISA) to quantitatively measure production of antibodies against the 30-kD protein in B cells from CSF of TBM and PTPM patients. Results: The cell ELISA yielded 92% (11/12) sensitivity and 92% (11/12) specificity for the differential diagnosis of TBM from PTPM. Conclusion: When induced with the 30-kD protein antigen, B cells derived from CSF of TBM patients respond to IgG production within 24 h while those derived from PTPM patients do not respond.
- 22 October 2004
- Published by Springer Nature in BMC Neurology
- Vol. 4 (1) , 16
Open AccessDifferential diagnosis of tuberculous meningitis from partially-treated pyogenic meningitis by cell ELISA
Background: Tuberculous meningitis (TBM) is a major global health problem, and it is sometimes difficult to perform a differential diagnosis of this disease from other diseases, particularly partially-treated pyogenic meningitis (PTPM). In an earlier study, we demonstrated the presence of a 30-kD protein antigen in cerebrospinal fluid (CSF) of TBM patients. We have also shown that lymphocytes from CSF of TBM patients respond differently to this antigen than do those from PTPM patients. The purpose of this study was to develop an assay that can discriminate between TBM and PTPM. Methods: We developed a cell enzyme-linked immunosorbant assay (Cell ELISA) to quantitatively measure production of antibodies against the 30-kD protein in B cells from CSF of TBM and PTPM patients. Results: The cell ELISA yielded 92% (11/12) sensitivity and 92% (11/12) specificity for the differential diagnosis of TBM from PTPM. Conclusion: When induced with the 30-kD protein antigen, B cells derived from CSF of TBM patients respond to IgG production within 24 h while those derived from PTPM patients do not respond.